Earthquakes and Mountain Building


-Research 5 types of mountains. For each type provide an image, describe physical characteristics along with how they formed, and apply Plate Tectonics to the kind of mountain building.
-Pick a mountain range: Andes, Alps, Appalachians, Himalayas, or Rockies. Describe and defend what type of mountain formation.
-Research about earthquakes and write a detailed summary of the different types of earthquakes and where they are located around the world and why are they located in specific locations.
-Could humans live in places along the Wasatch Front?
-How does plate tectonics explain where and why earthquakes and volcanoes occur where they do?
-What role do earthquakes and volcanoes have on civilization? What benefits do they bring us?
-How could understanding Earth’s tectonic forces help save lives?

Sample Solution

loss (PBAC score) was 172.08±41.50 which reduced to 11.76±22.72 at 3 months and 3.97±10.96 at 6 months with treatment. There was significant reduction in menstrual blood loss in patients with levonorgesterol IUCD. The results of this study (table-2) suggests that the rise in haemoglobin level at the end of 6 months of treatment was 10.64±1.99 compared to the pretreatment level of 9.78±1.29. The rise in haemoglobin level at the end of 6 months was significant. The mean endometrial thickness (Table-2) in the pretreatment group was 10.02±3.15 and there was decrease in mean endometrial thickness at the end of 6 months 5.43±1.21 of treatment with levonorgesterol IUCD.
Shalini et al[7] studied 40 patients with dysfunctional uterine bleeding and found a statistically significant increase in haemoglobin concentration (9.84 to 10.06g/dl) and fall in mean PBAC score of 199.45±30.23 before treatment to 53.18±14.73 after 6 months of treatment with levonorgesterol IUCD.
Taru G et al[2] studied 70 women with levonorgesterol IUCD insertion for heavy menstrual bleeding which resulted in reduction in menstrual blood loss to 79% after 6 months of insertion. Improvement in haemoglobin levels from 8.16 to 9.35±0.7g% by 6 months.
There are no much studies conducted comparing oral ormeloxifene and levonorgesterol IUCD in the management of dysfunctional uterine bleeding.
In our study, no major side effects were seen with both oral ormeloxifene and levonorgesterol IUCD. Only 4 patients out of 40 treated with levonorgesterol IUCD had history of spotting pervagina.
In our study both oral ormeloxifene and levonorgesterol IUCD had significant reduction in pictorial blood loss assessment chart score , decrease in endometrial thickness and increase in haemoglobin concentration after treatment for 6 months in patients with dysfunctional uterine bleeding.
Both oral ormeloxifene and levonorgestrel IUCD treatment modalities were safe. Both were efficacious in treatment of dysfunctional uterine bleeding. No statistical significant differe

This question has been answered.

Get Answer
WeCreativez WhatsApp Support
Our customer support team is here to answer your questions. Ask us anything!
👋 Hi, Welcome to Compliant Papers.